These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9030909)

  • 1. Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor.
    Ojima M; Inada Y; Shibouta Y; Wada T; Sanada T; Kubo K; Nishikawa K
    Eur J Pharmacol; 1997 Jan; 319(1):137-46. PubMed ID: 9030909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the antagonist [3H]candesartan to angiotensin II AT1 receptor-transfected [correction of tranfected] Chinese hamster ovary cells.
    Fierens F; Vanderheyden PM; De Backer JP; Vauquelin G
    Eur J Pharmacol; 1999 Feb; 367(2-3):413-22. PubMed ID: 10079018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
    Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
    Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
    Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors.
    Vanderheyden PM; Fierens FL; De Backer JP; Fraeyman N; Vauquelin G
    Br J Pharmacol; 1999 Feb; 126(4):1057-65. PubMed ID: 10193788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist.
    Noda M; Shibouta Y; Inada Y; Ojima M; Wada T; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    Biochem Pharmacol; 1993 Jul; 46(2):311-8. PubMed ID: 8347154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic studies on the interaction of nonlabeled antagonists with the angiotensin II receptor.
    Hara M; Kiyama R; Nakajima S; Kawabata T; Kawakami M; Ohtani K; Itazaki K; Fujishita T; Fujimoto M
    Eur J Pharmacol; 1995 Apr; 289(2):267-73. PubMed ID: 7621900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist.
    Hong KW; Kim CD; Lee SH; Yoo SE
    Fundam Clin Pharmacol; 1998; 12(1):64-9. PubMed ID: 9523186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.
    Vanderheyden PM; Fierens FL; De Backer J; Vauquelin G
    Biochem Pharmacol; 2000 Apr; 59(8):927-35. PubMed ID: 10692557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
    Wang QD; Sjöquist PO
    Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
    Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M
    Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations.
    Zhang J; Pfaffendorf M; Zhang JS; Van Zwieten PA
    Eur J Pharmacol; 1994 Feb; 252(3):337-40. PubMed ID: 8162955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
    Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS
    J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.